Evidence map›Paper›PMID 35216029›Full record

ArticleViruses2022

V5 and GFP Tagging of Viral Gene pp38 of Marek's Disease Vaccine Strain CVI988 Using CRISPR/Cas9 Editing.

Weicheng Li, Yaoyao Zhang, Katy Moffat, Venugopal Nair, Yongxiu Yao

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 54% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Weicheng LiViral Oncogenesis Group, The Pirbright Institute, Pirbright, Guildford GU24 0NF, UK.
Yaoyao ZhangViral Oncogenesis Group, The Pirbright Institute, Pirbright, Guildford GU24 0NF, UK.
Katy MoffatViral Oncogenesis Group, The Pirbright Institute, Pirbright, Guildford GU24 0NF, UK.ORCID 0000-0003-0120-7196
Venugopal NairViral Oncogenesis Group, The Pirbright Institute, Pirbright, Guildford GU24 0NF, UK.ORCID 0000-0002-8255-516X
Yongxiu YaoViral Oncogenesis Group, The Pirbright Institute, Pirbright, Guildford GU24 0NF, UK.
The Pirbright Institute · GB

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00007038Biotechnology and Biological Sciences Research Council BBS/E/I/00007039
6 · The paper itself

Abstract

Marek's disease virus (MDV) is a member of alphaherpesviruses associated with Marek's disease, a highly contagious neoplastic disease in chickens. The availability of the complete sequence of the viral genome allowed for the identification of major genes associated with pathogenicity using different techniques, such as bacterial artificial chromosome (BAC) mutagenesis and the recent powerful clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9)-based editing system. Thus far, most studies on MDV genome editing using the CRISPR/Cas9 system have focused on gene deletion. However, analysis of the expression and interactions of the viral proteins during virus replication in infected cells and tumor cells is also important for studying its role in MDV pathogenesis. The unavailability of antibodies against most of the MDV proteins has hindered the progress in such studies. This prompted us to develop pipelines to tag MDV genes as an alternative method for this purpose. Here we describe the application of CRISPR/Cas9 gene-editing approaches to tag the phosphoprotein 38 (pp38) gene of the MDV vaccine strain CVI988 with both V5 and green fluorescent protein (GFP). This rapid and efficient viral-gene-tagging technique can overcome the shortage of specific antibodies and speed up the MDV gene function studies significantly, leading to a better understanding of the molecular mechanisms of MDV pathogenesis.

Indexed as

AnimalsChickensCRISPR-Cas SystemsGene EditingGenome, ViralGreen Fluorescent ProteinsMardivirusMarek DiseaseMarek Disease VaccinesPhosphoproteinsPoultry DiseasesViral Envelope ProteinsVirus ReplicationGreen Fluorescent ProteinsMarek Disease VaccinesPhosphoproteinsViral Envelope ProteinsCRISPR/Cas9GFPMDVpp38taggingV5

Identifiers

PMID35216029
PMCPMC8879161
OpenAlexW4212798786

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.